The largest database of trusted experimental protocols

Easysep cd8 t cell negative selection kit

Manufactured by STEMCELL
Sourced in Canada

The EasySep CD8+ T cell negative selection kit is a laboratory tool used to isolate CD8+ T cells from a mixed cell population. It utilizes an antibody-based approach to selectively remove non-CD8+ T cells, thereby enriching the CD8+ T cell fraction. The kit provides a simple and efficient method for the purification of CD8+ T cells for various research applications.

Automatically generated - may contain errors

8 protocols using easysep cd8 t cell negative selection kit

1

In Vitro T Cell Stimulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro stimulation T cell assay by OVA257-264, GA-OVA, CBP-12-OVA or PBS was performed as described previously 23 (link). FL-DCs were incubated with 10 μg/mL OVA257-264, GA-OVA, CBP-12-OVA or PBS for 1.5 h at 4 °C, and then the peptide-loaded FL-DCs were washed three times. Meanwhile, CD8+ T cells were isolated using EasySepTM CD8+ T cell negative selection kit (STEMCELL, Vancouver, BC, Canada) from OT-1 mice. After labeling CD8+ T cells with 2 μΜ CFSE (eBioscience, San Diego, CA, US), 1 × 105 CD8+ T cells per well were plated into round-bottom 96-well plates. After 30 min, 1 × 104 peptide-loaded FL-DCs per well were gently added to the plates and incubated with CD8+ T cells for 72 h. Proliferation of DC-primed CD8+ T cells was determined by CFSE dilution. The cells were incubated with anti-mouse-CD3-PerCP-eFlour710 (17A2) and anti-mouse-CD8-APC (53-6.7) or Rat IgG2a-APC kappa Isotype Control (eBR2a), CD8+ T cells proliferation were detected by a flow cytometry. Supernatant was assayed for IFN-γ by a Mouse IFN-gamma ELISA kit (Thermo Fisher Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand
2

In vitro T cell activation assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro peptide stimulation T cell assays were performed using a modification of a previously described protocol [32 (link)]. In brief, 10μg/mL peptides (peptide-OVA257-264, OVA257-264, WH or NS) were incubated with FL-DC Day12 for 1.5 h at 4°C, by which the end time the peptide-loaded FL-DCs were washed three times. Meanwhile, OT-I CD8+ T cells were isolated using EasySepTM CD8+ T cell negative selection kit (Stemcell Technologies). Subsequently, the CD8+ T cells were seeded at 105 cells per well at round-bottom 96-well plates for 30 min. The peptide-loaded FL-DCs were then gently added at 104 cells per well to the final volume of 200μL. After incubation for 72 h, Supernatants were assayed for IFN-γ by ELISA. Perforin and granzyme mRNA expression were tested by qRT-PCR. The perforin forward and reverse primers are 5′-AGCACAAGTTCGTGCCA GG-3′ and 5′-GCGTCTCTCATTAGGGAGTTTT T-3′, respectively. The granzyme B forward and reverse primers are 5′-CCACTCTCGACCCTACATGG-3′ and 5′- GGCCCCCAAAGTGACATTTATT-3′, respectively. The β-actin forward and reverse primers are 5′-GTGGCATCCATGAAACT ACAT-3′ and 5′- GGCATAGAGGTCTTTACGG-3′, respectively. For T cell proliferation assay, the CD8+ T cells were stained with 2μM CFSE. Three days later, CD8+ T cell proliferation was determined by CFSE dilution.
+ Open protocol
+ Expand
3

Isolation of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-cell suspension of splenocytes were prepared to isolate DCs, macrophages, eosinophils, CD4+ and CD8+ T cells. DCs were isolated by DC isolation micro-bread kit (StemCell) in line with manufacturer’s instructions. DCs with a purity of >90% were used for experiments. For macrophages isolation, splenocytes were plated in DMEM supplemented with 10% FBS at 37 °C in a humidified 5% CO2 incubator for 1 h, then the supernatant fraction was poured off and the adherent splenocyte fraction was processed for CD68+ macrophages isolation by using EasySepTM PE positive selection kit (StemCell) in line with manufacturer’s instructions. Macrophages with a purity of >90% were used for experiments. Siglec-F+ eosinophils were isolated by using EasySepTM PE positive selection kit (StemCell) in line with manufacturer’s instructions. Eosinophils with a purity of >90% were used for experiments. CD4+ and CD8+ T cells were isolated by EasysepTM CD4+ T cell negative selection kit and EasysepTM CD8+ T cell negative selection kit (StemCell), respectively. CD4+ and CD8+ T cells with a purity of >90% were used for experiments.
+ Open protocol
+ Expand
4

Single-cell RNA-seq of LCMV-specific CD8+ T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD62Lhi, IL-7Rαhi and KLRG1hi P14 CD8+ T cells were sorted from d8 LCMV-Arm infected mice and naive P14 CD8+ T cells were sorted from uninfected P14 mice. Three replicates were processed separately using CD8+ T cell enrichment (using EasySep CD8+ T cell negative selection kit, Stem Cell Technologies), and staining of single-cell suspensions. CD62Lhi, IL-7Rαhi and KLRG1hi subsets were sorted to >98% purity for each replicate. RNA, was extracted in RLT buffer supplemented with β-mercaptoethanol and processed with a RNeasy Micro Kit (Qiagen) as per the manufacturer’s instructions. Total RNA libraries were prepared using a SMART-Seq Stranded Kit (Takara). Extracted RNA and libraries were assessed for quality on a TapeStation 2200 instrument (Agilent). RNA libraries were quantified using a KAPA Library Quantification Kit and sequenced on an Illumina NextSeq 550 instrument (150 bp, paired-end) on high-output flow cells.
+ Open protocol
+ Expand
5

OT-1 CD8+ T Cell Priming

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD8+ T cells were purified (EasySep CD8+ T cell negative selection kit, Stem Cell Technologies, Vancouver, British Columbia) from OT-1 mice, and incubated with activated BM-dendritic cells isolated form WT Act-mOVA or B7-H1 KO Act-mOVA mice. After 20 or 4 hours of co-culture, CD11c+ dendritic cells were removed from culture by a magnetized MACS column (Miltenyi Biotec). The primed CD8+ T cells were cultured in fresh medium in a new culture plate for additional 40 hours before functional assay or transfer.
+ Open protocol
+ Expand
6

Treg Suppression Assay of IL-2 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the activity of IL-2-treated Treg cells, purified CD8+ T cells were used as responder cells in a Treg:CD8 T coculture system. CD8+ T cells were purified from PBMCs isolated from healthy human donor derived leukopaks (AllCells) using EasySep CD8+ T cell Negative selection kit (STEMCELL Technologies) and were cultured with purified and pre-stimulated (as described in the human Treg cell purification and stimulation section) human Treg cells at varying ratios, in the presence of anti-CD3/anti-CD28 magnetic DynaBeads (Invitrogen) added at 1:12 bead:T cell ratio. Suppression was measured by inhibition of activation marker CD25 expression on responder CD8+ T cells after overnight incubation at 37°C.
Percent suppression was calculated using changes in CD25 MFI as a measure of activation in responder CD8 T cells using the following formula:
Statistical data analysis was performed using GraphPad Prism software (v7.04, GraphPad Software, Inc.). To compare the effect of different IL-2 muteins and WTIL2-Fc in Treg suppression assay, 2-way ANOVA test was used with Tukey post-hoc test.
+ Open protocol
+ Expand
7

CD8+ T Cell Activation and PD-L1 Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
The spleen and lymph nodes of WT and CD80-KO mice were harvested at 6–12 weeks of age. The cells were activated with concanavalin A (ConA, 5 μg/mL, L7647, Sigma-Aldrich) for 48 hours. Following activation, CD8+ T cells were purified from the whole cell population (EasySep CD8+ T cell negative selection kit, Stem Cell Technologies) and were incubated with plate-bound PD-L1/Fc or recombinant human IgG1/Fc (control/Fc) fusion proteins (R&D Systems) for 48 hours in the presence of anti-CD3 (clone 2C11, BD Biosciences) in ConA-conditioned media (RPMI 1640 medium with L-glutamine and 25 mM HEPES (Lonza) with 10% FBS (Gibco), 1 U/mL penicillin (Gibco), and 1 μg/mL streptomycin (Gibco)). Live cells were counted by Trypan blue (Millipore) exclusion using a hemocytometer.
+ Open protocol
+ Expand
8

T Cell Isolation and Enrichment

Check if the same lab product or an alternative is used in the 5 most similar protocols
For isolation of CD4+ and CD8+ T cells, spleens from the treated mice and 4T1 tumor-bearing control mice were harvested on day 21 after treatment, and single cell suspensions were prepared using a GentleMACS dissociator (Miltenyi Biotec). CD4+ and CD8+ T cells were isolated by an Easysep CD4+ T cell negative selection kit and an Easysep CD8+ T cell negative selection kit (StemCell Technologies, Vancouver, BC, Canada), respectively. CD4+ and CD8+ T cells with a purity of >90% were used for experiments. For isolation of Tregs, the isolated CD4+ T cells were then incubated with CD25-PE (clone 3C7, Biolegend, USA) and isolated with a PE positive selection kit (StemCell Technologies, Canada). The isolated cells were then verified by flow cytometry, and more than 85% of cells expressed Foxp3.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!